Table 1.

Observed BAM + ETE serum concentrations on day 29

Weight cohort (n)	BAM dose	Geometric mean, µg/ml (CV%)	ETE dose	Geometric mean, µg/ml (CV%)
Adults ≥ 18 years of agea	700 mg	25.7 (42.9)	1400 mg	116 (38.1)
≥ 40 kg (n = 65b)	700 mg	29.9 (54.4%)	1400 mg	140 (44.0%)
> 20 kg to < 40 kg (n = 18)	350 mg	23.7 (45.6%)	700 mg	129 (36.7%)
> 12 kg to ≤ 20 kg (n = 10)	175 mg	21.2 (74.0%)	350 mg	122 (57.3%)
≥ 1.5 kg to ≤ 12 kg (n = 3)	15 mg/kg	40.2 (23.2%)	30 mg/kg	193 (11.0%)

BAM bamlanivimab, ETE etesevimab, CV% coefficient of variation as percent

^an = 311 in observed BAM serum concentrations and n = 320 in observed ETE serum concentrations

^bn = 64 in observed BAM serum concentrations